CYTK
Cytokinetics Incorporated
Latest News for CYTK
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cytokinetics (CYTK – Research Report) and Rhythm Pha......
In a report released on January 21, Leonid Timashev from RBC Capital maintained a Buy rating on Cytokinetics, with a price target of $95.00. The co......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Anavex Life Sciences (AVXL – Research Report), Cytok......
Which stocks are best to buy now? According to Top Wall Street Analysts, the three stocks listed below are Strong Buys. Each stock received a new B......
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Cytokinetics (CYTK – Research Report) and Pfizer (......
In a report released yesterday, Roanna Ruiz from Leerink Partners reiterated a Buy rating on Cytokinetics. The company’s shares closed yesterday at......
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Amgen (AMGN – Research Report), Cytokinetics (CYTK –......
In a report released today, Jason Zemansky from Bank of America Securities maintained a Hold rating on Cytokinetics, with a price target of $65.00.......
News data is sourced from MarketXLS API and updated regularly.
Showing 8 of 8 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CYTK | $64.70 | -0.7% | 966.10K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Cytokinetics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW